drugset / Trial / NCT07434492

Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy

NCT07434492 ↗

Phase 2 Recruiting 60 enrolled Shirley Ryan AbilityLab
RandomizedParallel-groupTriple-blindOther

Summary

This is an intervention study to investigate the impact of a smart ankle-foot orthosis (AFO) on mobility outcomes in children with Cerebral Palsy. Participants will complete a three phase protocol including 6-weeks of at home training with the smart AFO. Participants will also have the option to participate in a randomized control trial to investigate the impact of 5-Azacitidine combined with the smart AFO to further effect mobility outcomes.

Timeline

Start
2026-05-28
Primary completion
2030-08-31
Completion
2030-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Azacitidine Other / unclassified 75 mg/m2 Subcutaneous

Indications